The development of new probiotics based on lactic acid bacteria genus Lactobacillus
Multiprobiotic drug was created on a base of 5 strains of bacteria p. Lactobacillus. The product is characterized by high antagonistic activity in point of pathogenic and conditionally pathogenic bacteria, ability to adhesion of epithelial cells of the intestinal mucosa and resistance to aggressive gastrointestinal mediums. Probiotic is showed antimutagenic and antiherpetic activity, immunological regulations and involved in metabolism of bile and gonadal hormones.